S&P 500   2,737.92 (+2.79%)
DOW   23,399.11 (+3.17%)
QQQ   201.28 (+2.44%)
AAPL   268.01 (+2.11%)
FB   172.37 (+4.11%)
MSFT   168.22 (+1.78%)
GOOGL   1,214.27 (+2.63%)
AMZN   2,029.46 (+1.60%)
CGC   15.22 (+6.14%)
BABA   199.91 (+1.76%)
MU   47.57 (+2.59%)
GE   7.40 (+2.21%)
TSLA   539.66 (+4.54%)
AMD   48.53 (+2.13%)
T   30.53 (+3.70%)
ACB   0.84 (+5.03%)
NFLX   377.23 (-0.72%)
BAC   22.62 (+5.75%)
GILD   74.96 (-3.56%)
DIS   103.69 (+3.52%)
PRI   91.27 (+4.80%)
S&P 500   2,737.92 (+2.79%)
DOW   23,399.11 (+3.17%)
QQQ   201.28 (+2.44%)
AAPL   268.01 (+2.11%)
FB   172.37 (+4.11%)
MSFT   168.22 (+1.78%)
GOOGL   1,214.27 (+2.63%)
AMZN   2,029.46 (+1.60%)
CGC   15.22 (+6.14%)
BABA   199.91 (+1.76%)
MU   47.57 (+2.59%)
GE   7.40 (+2.21%)
TSLA   539.66 (+4.54%)
AMD   48.53 (+2.13%)
T   30.53 (+3.70%)
ACB   0.84 (+5.03%)
NFLX   377.23 (-0.72%)
BAC   22.62 (+5.75%)
GILD   74.96 (-3.56%)
DIS   103.69 (+3.52%)
PRI   91.27 (+4.80%)
S&P 500   2,737.92 (+2.79%)
DOW   23,399.11 (+3.17%)
QQQ   201.28 (+2.44%)
AAPL   268.01 (+2.11%)
FB   172.37 (+4.11%)
MSFT   168.22 (+1.78%)
GOOGL   1,214.27 (+2.63%)
AMZN   2,029.46 (+1.60%)
CGC   15.22 (+6.14%)
BABA   199.91 (+1.76%)
MU   47.57 (+2.59%)
GE   7.40 (+2.21%)
TSLA   539.66 (+4.54%)
AMD   48.53 (+2.13%)
T   30.53 (+3.70%)
ACB   0.84 (+5.03%)
NFLX   377.23 (-0.72%)
BAC   22.62 (+5.75%)
GILD   74.96 (-3.56%)
DIS   103.69 (+3.52%)
PRI   91.27 (+4.80%)
S&P 500   2,737.92 (+2.79%)
DOW   23,399.11 (+3.17%)
QQQ   201.28 (+2.44%)
AAPL   268.01 (+2.11%)
FB   172.37 (+4.11%)
MSFT   168.22 (+1.78%)
GOOGL   1,214.27 (+2.63%)
AMZN   2,029.46 (+1.60%)
CGC   15.22 (+6.14%)
BABA   199.91 (+1.76%)
MU   47.57 (+2.59%)
GE   7.40 (+2.21%)
TSLA   539.66 (+4.54%)
AMD   48.53 (+2.13%)
T   30.53 (+3.70%)
ACB   0.84 (+5.03%)
NFLX   377.23 (-0.72%)
BAC   22.62 (+5.75%)
GILD   74.96 (-3.56%)
DIS   103.69 (+3.52%)
PRI   91.27 (+4.80%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 BG MedicineFluoropharma MedicalResponse GeneticsAkers BiosciencesAchieve Life Sciences
SymbolOTCMKTS:BGMDOTCMKTS:FPMIOTCMKTS:RGDXQNASDAQ:AKERNASDAQ:ACHV
Price Information
Current Price$0.03$0.01$0.00$8.20$0.32
52 Week RangeN/AN/AN/AN/ABuy
Analyst Ratings
Consensus RecommendationN/AN/AN/AN/ABuy
Consensus Price TargetN/AN/AN/AN/A$9.33
% Upside from Price TargetN/AN/AN/AN/A2,816.67% upside
Trade Information
Market Cap$330,000.00N/AN/A$5.12 million$9.91 million
Beta1.171.870.6-0.431.62
Average Volume12,4523,57056,436410,920870,447
Sales & Book Value
Annual RevenueN/AN/AN/A$1.58 millionN/A
Price / SalesN/AN/AN/A14.01N/A
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book ValueN/AN/AN/A$5.38 per share$0.61 per share
Price / BookN/AN/AN/A1.52N/A
Profitability
Net IncomeN/AN/AN/A$-3,890,000.00$-16,400,000.00
EPSN/AN/AN/AN/A($1.99)
Trailing P/E Ratio0.000.000.00N/AN/A
Forward P/E RatioN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/AN/A-246.54%N/A
Return on Equity (ROE)N/AN/AN/A-69.95%-136.96%
Return on Assets (ROA)N/AN/AN/A-53.94%-106.07%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/AN/AN/AN/A0.01%
Current RatioN/AN/AN/A6.74%6.04%
Quick RatioN/AN/AN/A6.61%6.04%
Ownership Information
Institutional Ownership PercentageN/AN/AN/AN/A42.16%
Insider Ownership Percentage6.50%36.90%4.85%0.36%6.80%
Miscellaneous
Employees54961313
Shares Outstanding11.37 millionN/AN/A2.70 million31.35 million
Next Earnings DateN/AN/AN/A5/18/2020 (Estimated)5/20/2020 (Estimated)
OptionableNot OptionableNot OptionableNot OptionableNot OptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel